Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
1.550
-0.050 (-3.13%)
Sep 2, 2026, 3:32 PM EDT - Market open
Imunon Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| - | - | - | - | 0.5 | 0.5 | |
Revenue Growth | - | - | - | - | 0% | 0% |
Cost of Revenue | 0.41 | - | - | - | - | 10.62 |
Gross Profit | -0.41 | - | - | - | 0.5 | -10.12 |
Selling, General & Admin | 6.65 | 6.87 | 7.49 | 9.74 | 13.69 | 10.89 |
Research & Development | 7.78 | 7.78 | 11.64 | 11.29 | 11.73 | - |
Operating Expenses | 14.43 | 14.65 | 19.13 | 21.03 | 25.42 | 10.89 |
Operating Income | -14.84 | -14.65 | -19.13 | -21.03 | -24.92 | -21.01 |
Interest Expense | -0.08 | - | - | -0.2 | -5.03 | -0.57 |
Interest & Investment Income | 0.18 | 0.16 | 0.51 | 1.16 | 0.45 | 0.01 |
Other Non Operating Income (Expenses) | 0.02 | - | - | -0.4 | 0 | 0 |
EBT Excluding Unusual Items | -14.72 | -14.5 | -18.62 | -20.47 | -29.5 | -21.56 |
Impairment of Goodwill | - | - | - | - | - | -1.98 |
Other Unusual Items | - | - | - | -0.33 | 5.4 | 1.39 |
Pretax Income | -14.72 | -14.5 | -18.62 | -20.8 | -37.47 | -22.15 |
Income Tax Expense | - | - | - | -1.28 | -1.57 | -1.38 |
Net Income | -14.72 | -14.5 | -18.62 | -19.51 | -35.9 | -20.77 |
Preferred Dividends & Other Adjustments | 0.02 | - | - | - | - | - |
Net Income to Common | -14.73 | -14.5 | -18.62 | -19.51 | -35.9 | -20.77 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 4 | 2 | 1 | 1 | 1 | 0 |
Shares Outstanding (Diluted) | 4 | 2 | 1 | 1 | 1 | 0 |
Shares Change | 217.32% | 93.23% | 58.46% | 26.63% | 31.62% | 154.70% |
EPS (Basic) | -3.57 | -6.83 | -16.94 | -28.14 | -65.55 | -49.92 |
EPS (Diluted) | -3.57 | -6.83 | -16.94 | -28.14 | -65.55 | -49.92 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -15.18 | -14.18 | -18.88 | -19.47 | -23.36 | -16.54 |
Free Cash Flow Per Share | -3.68 | -6.68 | -17.18 | -28.08 | -42.66 | -39.74 |
Gross Margin | - | - | - | - | 100.00% | - |
Operating Margin | - | - | - | - | -4984.31% | -4201.44% |
Profit Margin | - | - | - | - | -7179.65% | -4153.85% |
Free Cash Flow Margin | - | - | - | - | -4672.94% | -3307.04% |
EBITDA | -14.55 | -14.36 | -18.89 | -20.78 | -24.73 | -20.3 |
D&A For EBITDA | 0.29 | 0.29 | 0.24 | 0.25 | 0.2 | 0.7 |
EBIT | -14.84 | -14.65 | -19.13 | -21.03 | -24.92 | -21.01 |